Tradition Capital Management LLC reduced its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 3.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,642 shares of the medical research company’s stock after selling 901 shares during the quarter. Thermo Fisher Scientific accounts for approximately 1.4% of Tradition Capital Management LLC’s investment portfolio, making the stock its 22nd largest holding. Tradition Capital Management LLC’s holdings in Thermo Fisher Scientific were worth $5,248,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Beach Investment Management LLC. raised its holdings in Thermo Fisher Scientific by 1,702.8% in the second quarter. Beach Investment Management LLC. now owns 71,661 shares of the medical research company’s stock worth $12,503,000 after purchasing an additional 67,686 shares in the last quarter. Atlantic Trust Group LLC raised its holdings in Thermo Fisher Scientific by 0.3% in the second quarter. Atlantic Trust Group LLC now owns 565,848 shares of the medical research company’s stock worth $98,723,000 after purchasing an additional 1,472 shares in the last quarter. Calamos Wealth Management LLC raised its holdings in Thermo Fisher Scientific by 1.2% in the second quarter. Calamos Wealth Management LLC now owns 15,876 shares of the medical research company’s stock worth $2,770,000 after purchasing an additional 184 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. raised its holdings in Thermo Fisher Scientific by 1,199.6% in the second quarter. Los Angeles Capital Management & Equity Research Inc. now owns 69,542 shares of the medical research company’s stock worth $12,133,000 after purchasing an additional 64,191 shares in the last quarter. Finally, Glassman Wealth Services raised its holdings in Thermo Fisher Scientific by 23.1% in the second quarter. Glassman Wealth Services now owns 1,039 shares of the medical research company’s stock worth $181,000 after purchasing an additional 195 shares in the last quarter. Hedge funds and other institutional investors own 86.31% of the company’s stock.

Several research firms have recently issued reports on TMO. Deutsche Bank set a $226.00 price objective on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a report on Thursday, October 26th. Zacks Investment Research downgraded shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Monday, October 30th. Leerink Swann restated a “buy” rating on shares of Thermo Fisher Scientific in a report on Monday, October 30th. Evercore ISI began coverage on shares of Thermo Fisher Scientific in a report on Wednesday, January 3rd. They set an “outperform” rating and a $220.00 price objective on the stock. Finally, BTIG Research began coverage on shares of Thermo Fisher Scientific in a report on Friday, January 5th. They set a “buy” rating and a $230.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $220.50.

In related news, SVP Gregory J. Herrema sold 33,327 shares of the company’s stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $219.70, for a total value of $7,321,941.90. Following the sale, the senior vice president now owns 60,471 shares in the company, valued at $13,285,478.70. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Marc N. Casper sold 50,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 15th. The shares were sold at an average price of $188.39, for a total value of $9,419,500.00. Following the completion of the sale, the chief executive officer now owns 252,577 shares in the company, valued at approximately $47,582,981.03. The disclosure for this sale can be found here. In the last quarter, insiders sold 144,327 shares of company stock worth $28,680,042. 0.49% of the stock is owned by insiders.

Shares of Thermo Fisher Scientific Inc. (TMO) opened at $200.18 on Friday. The company has a market capitalization of $79,689.81, a P/E ratio of 20.96, a P/E/G ratio of 1.46 and a beta of 1.11. Thermo Fisher Scientific Inc. has a 52-week low of $151.74 and a 52-week high of $226.44. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.35 and a quick ratio of 0.92.

Thermo Fisher Scientific (NYSE:TMO) last issued its earnings results on Wednesday, January 31st. The medical research company reported $2.79 EPS for the quarter, beating the Zacks’ consensus estimate of $2.66 by $0.13. The firm had revenue of $6.05 billion for the quarter, compared to analyst estimates of $5.72 billion. Thermo Fisher Scientific had a return on equity of 16.01% and a net margin of 10.64%. Thermo Fisher Scientific’s revenue for the quarter was up 22.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.41 earnings per share. equities analysts expect that Thermo Fisher Scientific Inc. will post 10.81 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, April 16th. Investors of record on Thursday, March 15th will be given a $0.17 dividend. The ex-dividend date of this dividend is Wednesday, March 14th. This represents a $0.68 dividend on an annualized basis and a yield of 0.34%. This is a positive change from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. Thermo Fisher Scientific’s dividend payout ratio is currently 10.71%.

COPYRIGHT VIOLATION WARNING: This piece of content was first posted by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/tradition-capital-management-llc-sells-901-shares-of-thermo-fisher-scientific-inc-tmo/1857241.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.